Detalhe da pesquisa
1.
Insight into the mechanism of CD34+ cell mobilisation impairment in multiple myeloma patients treated with anti-CD38 therapy.
Br J Haematol
; 204(4): 1439-1449, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37807708
2.
Natural killer cells: Innate immune system as a part of adaptive immunotherapy in hematological malignancies.
Am J Hematol
; 97(6): 802-817, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35285978
3.
Selected severe „haematological“ syndromes in adult intensive care patients.
Vnitr Lek
; 68(8): 498-507, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36575067
4.
Washing transplants with Sepax 2 reduces the incidence of side effects associated with autologous transplantation and increases patients' comfort.
Transfusion
; 61(8): 2430-2438, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34197635
5.
Large-Scale Automated Hollow-Fiber Bioreactor Expansion of Umbilical Cord-Derived Human Mesenchymal Stromal Cells for Neurological Disorders.
Neurochem Res
; 45(1): 204-214, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31828497
6.
Hospital-acquired methemoglobinemia.
Vnitr Lek
; 66(6): 46-52, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33380153
7.
HLA-B gene somatic insertion/deletion mutations in patients with acute myelogenous leukaemia.
Int J Immunogenet
; 45(6): 323-328, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30051604
8.
The impact of centralised care of younger AML patients on treatment results: a retrospective analysis of real-world data from a national population-based registry.
Acta Oncol
; 60(6): 818-823, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34048310
9.
Venetoclax plus bortezomib and dexamethasone in heavily pretreated end-stage myeloma patients without t(11;14): A real-world cohort.
Hematol Oncol
; 38(3): 412-414, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32323881
10.
Granulocyte maturation determines ability to release chromatin NETs and loss of DNA damage response; these properties are absent in immature AML granulocytes.
Biochim Biophys Acta
; 1833(3): 767-79, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23269287
11.
Single-agent venetoclax induces MRD-negative response in relapsed primary plasma cell leukemia with t(11;14).
Am J Hematol
; 94(1): E35-E37, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30370955
12.
Immunoablative therapy followed by autologous hematopoietic stem cell transplantation as the first-line disease-modifying therapy in patients with multiple sclerosis.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub
; 168(1): 50-54, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37337857
13.
Cost-effectiveness of hematopoietic stem cell mobilization strategies including plerixafor in multiple myeloma and lymphoma patients.
J Clin Apher
; 28(6): 395-403, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23922227
14.
Plerixafor for autologous peripheral blood stem cell mobilization in patients previously treated with fludarabine or lenalidomide.
Biol Blood Marrow Transplant
; 18(2): 314-7, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22001752
15.
European data on stem cell mobilization with plerixafor in patients with nonhematologic diseases: an analysis of the European consortium of stem cell mobilization.
Transfusion
; 52(11): 2395-400, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22414093
16.
Multiple myeloma patients at peripheral blood stem cell harvest: restricted usage of TCR beta variable families.
Clin Immunol
; 138(1): 67-76, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20947434
17.
Haematopoietic stem cell mobilization with plerixafor and G-CSF in patients with multiple myeloma transplanted with autologous stem cells.
Eur J Haematol
; 86(6): 488-95, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21410533
18.
Identification of prognostic factors for plerixafor-based hematopoietic stem cell mobilization.
Am J Hematol
; 86(7): 550-3, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21674573
19.
Efficacy and safety of peripheral blood stem cell collection in elderly donors; does age interfere?
J Clin Apher
; 26(1): 9-16, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21312254
20.
Selection, Expansion, and Unique Pretreatment of Allogeneic Human Natural Killer Cells with Anti-CD38 Monoclonal Antibody for Efficient Multiple Myeloma Treatment.
Cells
; 10(5)2021 04 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33919155